Methyldopa

Half-Life (t½)
PO: 2h · IV: 2h
Formula
C10H13NO4
Molecular Weight
211.22 g/mol
PubChem CID
38853
Aliases
Aldomet

Pharmacological Mechanism

Centrally-acting α2-adrenergic agonist (active metabolite α-methylnorepinephrine) — reduces sympathetic outflow. Preferred antihypertensive in pregnancy with the longest safety record. Hemolytic anemia + hepatotoxicity at chronic use.

Half-Life & Elimination Curve (PO: 2h · IV: 2h)

100%50%25%12.5%0%0h0×t½2h1×t½4h2×t½6h3×t½8h4×t½10h5×t½0×t½ (0h): 100% remaining (~2.54 mg/L)1×t½ (2h): 50% remaining (~1.27 mg/L)2×t½ (4h): 25% remaining (~0.636 mg/L)3×t½ (6h): 12.5% remaining (~0.318 mg/L)4×t½ (8h): 6.3% remaining (~0.159 mg/L)5×t½ (10h): 3.1% remaining (~79.5 µg/L)
Plasma (PO)t½ Decay (2h)
  • 0×t½0h100% (2.54 mg/L)
  • 1×t½2h50% (1.27 mg/L)
  • 2×t½4h25% (0.636 mg/L)
  • 3×t½6h12.5% (0.318 mg/L)
  • 4×t½8h6.3% (0.159 mg/L)
  • 5×t½10h3.1% (79.5 µg/L)
Elimination t½2h (PO)
Rate Constant (ke)0.347 h⁻¹
Time to Peak (Tmax)1.62h
Est. Peak (Cmax)2.54 mg/L
Clearance (CL)9.7 L/h
97% Washout (5×t½)10h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References